Adaptive PEO-based biointerfaces on magnesium alloys: Smart surfaces for localized drug delivery and biointegration
Source abstract
Abstract
Background Growing clinical interest in fully degradable implant materials that eliminate secondary removal procedures has positioned magnesium and its alloys at the forefront of biomaterials research due to their biodegradability, favorable mechanical properties, and biocompatibility. However, rapid corrosion, limited bioactivity, and insufficient antibacterial performance remain major obstacles to their clinical translation. Methods This comprehensive review systematically analyzes recent literature on drug-loaded plasma electrolytic oxidation (PEO) coatings applied to magnesium substrates, with particular focus on coating fabrication strategies, drug incorporation approaches, release behavior, and in-vitro and in-vivo performance reported using electrochemical, surface, and biological characterization techniques. Significant findings The reviewed studies demonstrate that PEO-based coatings significantly improve corrosion resistance and tribological performance while serving as effective platforms for localized drug delivery. Incorporation of antibiotics, anticancer agents, anti-inflammatory drugs, and bisphosphonates enables controlled release, enhanced osseointegration, improved biocompatibility, and strong antibacterial activity. Overall, drug-loaded PEO coatings effectively regulate magnesium degradation and function as multifunctional biointerfaces, highlighting their strong potential for next-generation biodegradable implant applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Bone Tissue Engineering Materials · Magnesium Oxide Properties and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Corrosion and corrosion-fatigue behavior of magnesium metal matrix composites for bio-implant applications: a review10.1016/j.jma.2023.04.010 ↗
2. Advances in the modification of magnesium-based biomaterials to address corrosion and corrosion-fatigue: a review of developments and prospects10.1016/j.jmrt.2024.04.038 ↗
3. Biodegradable magnesium alloys for orthopaedic applications: a review on corrosion, biocompatibility and surface modifications10.1016/j.msec.2016.06.020 ↗
4. Magnesium based implants for functional bone tissue regeneration – a review10.1016/j.jma.2021.08.017 ↗
5. Novel magnesium alloys developed for biomedical application: a review
6. Critical review on biodegradable and biocompatibility magnesium alloys: progress and prospects in bio-implant applications10.1016/j.inoche.2024.113111 ↗
7. Biodegradable magnesium metal matrix composites for biomedical implants: synthesis, mechanical performance, and corrosion behavior - a review10.1016/j.jmrt.2022.06.178 ↗
8. Research progress on the corrosion behavior of magnesium alloys in natural environments
9. Magnesium matrix nanocomposites for orthopedic applications: a review from mechanical, corrosion, and biological perspectives10.1016/j.actbio.2019.06.007 ↗
10. Corrosion behavior investigation of gallium coating on magnesium alloy in simulated body fluid10.1016/j.jmrt.2023.09.271 ↗
11. Biofunctionization of biodegradable magnesium alloy to improve the in vitro corrosion resistance and biocompatibility10.1016/j.apsusc.2018.04.235 ↗
12. The role of antibacterial metallic elements in simultaneously improving the corrosion resistance and antibacterial activity of magnesium alloys10.1016/j.matdes.2020.109350 ↗
13. Corrosion behavior of severely plastic deformed magnesium based alloys: a review10.3103/S1068375517050039 ↗
14. Advances in green inhibitors for corrosion protection of magnesium and its alloys: a comprehensive review10.1016/j.jallcom.2025.182690 ↗
15. Effect of acidic, alkaline and neutral post-treatments on in-vitro corrosion resistance and bioactivity of plasma electrolytic oxidised ZE41 magnesium alloy for temporary implant application10.1016/j.surfcoat.2025.132365 ↗
16. Surface modification of polymers by plasma treatments for the enhancement of biocompatibility and controlled drug release10.1016/j.surfcoat.2013.02.042 ↗
17. Micro and nano-enabled approaches to improve the performance of plasma electrolytic oxidation coated magnesium alloys10.1016/j.jma.2020.11.004 ↗
18. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices10.1016/j.addr.2009.11.003 ↗
19. In vitro performance of a LDH nano capsules in-situ incorporated PEO coating loaded with naproxen sodium on Mg alloy10.1016/j.corsci.2024.112625 ↗
20. Antibacterial bioactive coatings loaded ciprofloxacin on magnesium alloys by MAO-EPD technique for biomedical application10.1016/j.ceramint.2024.12.050 ↗
21. In situ synthesis and electrochemical corrosion behavior of plasma electrolytic oxidation coating containing an osteoporosis drug on AZ31 magnesium alloy10.1016/j.matchemphys.2024.128983 ↗
22. In vitro degradation, antibacterial activity and drug release of levofloxacin-loaded coatings on Mg alloy AZ31: the effect of chain length10.1016/j.porgcoat.2024.108327 ↗
23. Improvement of biological and corrosion behavior of plasma electrolytic oxidized Mg implant by 3D printed scaffold of amine-terminated PEG/PCL loaded with dexamethasone10.1016/j.porgcoat.2024.108705 ↗
24. Ciprofloxacin release and corrosion behaviour of a hybrid PEO/PCL coating on Mg3Zn0.4Ca alloy10.3390/jfb14020065 ↗
25. Hierarchical hybrid coatings with drug-eluting capacity for Mg alloy biomaterials10.3390/ma16247688 ↗
26. The enhanced antibacterial effect of BNNS_Van@CS/MAO coating on Mg alloy for orthopedic applications10.1016/j.colsurfb.2022.112971 ↗
27. Synthesis and characterization of ciprofloxacin-loaded biodegradable magnesium implants for the prevention of implant-associated infections10.1016/j.matchemphys.2023.127530 ↗
28. A drug-loaded bio-functional anticorrosion coating on Mg alloy for orthopedic applications10.1016/j.matlet.2021.131581 ↗
29. Corrosion resistance, antibacterial activity and drug release of ciprofloxacin-loaded micro-arc oxidation/silane coating on magnesium alloy AZ3110.1016/j.porgcoat.2021.106357 ↗
30. Nitrogen-containing bisphosphonate-loaded micro-arc oxidation coating for biodegradable magnesium alloy pellets inhibits osteosarcoma through targeting of the mevalonate pathway10.1016/j.actbio.2020.11.019 ↗
31. Improved corrosion performance of biodegradable magnesium in simulated inflammatory condition via drug-loaded plasma electrolytic oxidation coatings10.1016/j.matchemphys.2019.122003 ↗
32. Preparation of vancomycin-loaded alginate hydrogel coating on magnesium alloy with enhanced anticorrosion and antibacterial properties
33. Synthesis and in-vitro performance of nanostructured monticellite coating on magnesium alloy for biomedical applications10.1016/j.jallcom.2018.08.310 ↗
34. Functional PEO layers on magnesium alloys: innovative polymer-free drug-eluting stents10.1680/jsuin.18.00011 ↗
35. Sealing the pores of PEO coating with Mg-Al layered double hydroxide: enhanced corrosion resistance, cytocompatibility and drug delivery ability
36. Corrosion and drug release properties of EN-plating/PLGA composite coating on MAO film10.1016/j.msec.2011.04.005 ↗
37. Controllable biodegradability, drug release behavior and hemocompatibility of PTX-Eluting magnesium stents10.1016/j.colsurfb.2010.10.038 ↗
38. Cross-linked gelatin/nanoparticles composite coating on micro-arc oxidation film for corrosion and drug release10.1016/j.apsusc.2009.10.069 ↗
39. Optical emission spectroscopy studies of discharge mechanism and plasma characteristics during plasma electrolytic oxidation of magnesium in different electrolytes10.1016/j.surfcoat.2010.10.022 ↗
40. Development of corrosion and wear resistant micro-arc oxidation coating on a magnesium alloy10.1016/j.surfcoat.2018.10.089 ↗
41. Preparation and characterization of hydroxyapatite containing coating on AZ31 magnesium alloy by micro-arc oxidation10.1016/j.jallcom.2016.07.079 ↗
42. Corrosion behavior of composite coatings containing hydroxyapatite particles on Mg alloys by plasma electrolytic oxidation: a review10.1016/j.jma.2023.09.003 ↗
43. Effect of graphene oxide on properties of AZ91 magnesium alloys coating developed by micro-arc oxidation process10.1016/j.jallcom.2021.162106 ↗
44. Growth characteristics and corrosion resistance of micro-arc oxidation coating on pure magnesium for biomedical applications10.1016/j.corsci.2010.03.008 ↗
45. Synthesis and properties of hydroxyapatite-containing coating on AZ31 magnesium alloy by micro-arc oxidation10.1016/j.apsusc.2016.12.216 ↗
46. Preparation and characterization of the micro-arc oxidation composite coatings on magnesium alloys10.1016/j.jma.2014.11.006 ↗
47. A universal electrolyte for the plasma electrolytic oxidation of aluminum and magnesium alloys10.1016/j.matdes.2015.08.071 ↗
48. Forming characteristics and mechanisms of micro-arc oxidation coatings on magnesium alloys based on different types of single electrolyte solutions10.1016/j.ceramint.2023.07.202 ↗
49. Residual stresses in materials modified by plasma electrolytic oxidation: insights and implications for performance10.1016/j.progsurf.2025.100780 ↗
50. Photocatalytic active MgO/MgAl2O4 coatings doped with rare earth elements (Sm, Tb, Pr, Gd, and Nd) formed on AZ31 magnesium alloy by plasma electrolytic oxidation10.1016/j.jpcs.2025.113050 ↗
51. Impressive strides in amelioration of corrosion behavior of Mg-based alloys through the PEO process combined with surface laser process: a review10.1016/j.jma.2023.10.005 ↗
52. Improving the wear resistance of plasma electrolytic oxidation (PEO) coatings applied on Mg and its alloys under the addition of nano- and micro-sized additives into the electrolytes: a review10.1016/j.jma.2020.11.016 ↗
53. In vitro biological assessment of plasma electrolytic oxidation-treated magnesium alloys containing multiple nutrient elements10.1016/j.rineng.2025.106654 ↗
54. Developments in plasma electrolytic oxidation (PEO) coatings for biodegradable magnesium alloys10.1016/j.matpr.2021.02.650 ↗
55. Enhancing cytocompatibility, antibacterial activity and corrosion resistance of PEO coatings on titanium using incorporated ZrO2 nanoparticles
56. Incorporation of magnesium phosphate into magnesium oxide on Mg[sbnd]Ag alloy through plasma electrolytic oxidation10.1016/j.surfcoat.2022.128822 ↗
57. Functionalization treatment of micro-arc oxidation coatings on magnesium alloys: a review10.1016/j.jallcom.2021.160453 ↗
58. Comprehensive study on corrosion, wear and fatigue performance of low-porosity PEO coating on Mg alloy10.1016/j.jma.2025.01.023 ↗
59. Effect of PEO ceramic coating on AZ91D magnesium alloy under laser-assisted irradiation on the in-situ growth and corrosion resistance of MgAl-LDH film10.1016/j.jallcom.2025.180818 ↗
60. Superhydrophobic coating to delay drug release from drug-loaded electrospun fibrous materials10.1016/j.apsusc.2015.10.085 ↗
61. Drug release characteristics of quercetin-loaded TiO2 nanotubes coated with chitosan10.1016/j.ijbiomac.2016.04.034 ↗
62. Preparation and characterization of mesoporous HA coating with paclitaxel loaded lignin nanospheres on titanium surface10.1016/j.jor.2024.09.008 ↗
63. Effect of the porosity, roughness, wettability, and charge of micro-arc coatings on the efficiency of doxorubicin delivery and suppression of cancer cells10.3390/coatings10070664 ↗
64. Electrophoretically deposited mesoporous magnesium silicate with ordered nanopores as an antibiotic-loaded coating on surface-modified titanium10.1016/j.msec.2018.12.013 ↗
65. A HAase/NIR responsive surface on titanium implants for treating bacterial infection and improving osseointegration10.1016/j.jmst.2022.09.029 ↗
66. Biocompatibility analysis of titanium bone wedges coated by antibacterial ceramic-polymer layer10.1038/s41598-024-72931-w ↗
67. Improvement of biomedical properties of PEO-treated titanium with flurbiprofen and exosome conjugation
68. Antibacterial and cytocompatible coatings based on poly(adipic anhydride) for a Ti alloy surface
69. Physico-chemical and biological evaluation of doxycycline loaded into hybrid oxide-polymer layer on Ti–Mo alloy
70. Biodegradable Bi-layered coating on polymeric orthopaedic implants for controlled release of drugs10.1016/j.matlet.2014.06.070 ↗
71. Electrophoretic deposition of dexamethasone-loaded gelatin nanospheres/chitosan coating and its dual function in anti-inflammation and osteogenesis10.1016/j.colsurfb.2018.05.029 ↗
72. Hydrothermal synthesis of hierarchical hydroxyapatite: preparation, growth mechanism and drug release property10.1016/j.ceramint.2011.07.033 ↗
73. Three-dimensional bioprinting in drug delivery
74. Magnetic microspheres based on pectin coated by chitosan towards smart drug release10.1016/j.carbpol.2021.118013 ↗
75. Nanoparticles for drug delivery: insight into in vitro and in vivo drug release from nanomedicines10.1016/j.ntm.2025.100083 ↗
76. Metallic implant drug/device combinations for controlled drug release in orthopaedic applications10.1016/j.jconrel.2014.01.026 ↗
77. Release mechanisms and applications of drug delivery systems for extended-release10.1080/17425247.2020.1788541 ↗
78. Degradation behavior of polymers used as coating materials for drug delivery—a basic review10.3390/polym13081272 ↗
79. Kinetic modeling to explain the release of medicine from drug delivery systems10.1002/cben.202300027 ↗
80. Antibiotics bioremediation: perspectives on its ecotoxicity and resistance10.1016/j.envint.2018.12.065 ↗
81. Hybrid nanosystems of antibiotics with metal nanoparticles—novel antibacterial agents10.3390/molecules28041603 ↗
82. Recent advances in the development of bacterial response regulators inhibitors as antibacterial and/or antibiotic adjuvant agent: a new approach to combat bacterial resistance10.1016/j.bioorg.2024.107606 ↗
83. Antibiotics: conventional therapy and natural compounds with antibacterial activity-a pharmaco-toxicological screening10.3390/antibiotics10040401 ↗
84. Progress in the synthesis and applications of FDA-approved anticancer drugs: current trends and future perspectives10.1016/j.tet.2025.134833 ↗
85. Recent advances in the discovery of copper(II) complexes as potential anticancer drugs10.1016/j.ejmech.2025.117702 ↗
86. Chitosan nanoparticle delivery systems: an effective approach to enhancing efficacy and safety of anticancer drugs10.1016/j.ntm.2024.100040 ↗
87. Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles
88. Innovative insights into removing anticancer drugs as emerging contaminants: advances in detection, ecological risk, and bioremediation strategies10.1016/j.jwpe.2025.108492 ↗
89. Design, synthesis, anti-inflammatory evaluation and molecular docking of novel thiophen-2-ylmethylene-based derivatives as potential TNF-α production inhibitors10.1016/j.bioorg.2022.105726 ↗
90. Design, classification, and adverse effects of NSAIDs: a review on recent advancements10.1016/j.bmc.2024.117899 ↗
91. Coumarin: a natural solution for alleviating inflammatory disorders10.1016/j.crphar.2024.100202 ↗
92. Advancing fungal biodegradation of nonsteroidal anti-inflammatory drugs — challenges and future perspectives10.1016/j.copbio.2025.103293 ↗
93. Deep eutectic solvent systems as media for the selective extraction of anti-inflammatory bioactive agents10.3390/molecules30163357 ↗
94. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective10.1016/j.bcp.2020.114147 ↗
95. Corticosteroid use in musculoskeletal and neuraxial interventions: effects on glycemic control
96. Corticosteroid-induced psychiatric disorders: mechanisms, outcomes, and clinical implications10.3390/diseases12120300 ↗
97. Bisphosphonates and osteonecrosis of the jaws: clinical and forensic aspects10.1016/j.archoralbio.2023.105792 ↗
98. Bisphosphonates: synthesis, structures, properties, medical and industrial applications10.1016/j.molliq.2022.118619 ↗
99. Effect of locally delivered bisphosphonates on alveolar bone: a systematic review and meta-analysis
100. Orthodontics and bisphosphonates: risks, limitations, and considerations: a narrative review10.1053/j.sodo.2025.06.001 ↗